Summit Therapeutics (SMMT) Exchange Rate Effect (2019 - 2026)
Summit Therapeutics (SMMT) reported Exchange Rate Effect of -$19000.0 for Q1 2026, down 150.0% on a YoY basis from $38000.0 in Q1 2025, and little changed quarter-over-quarter from -$19000.0 in Q4 2025.
Summit Therapeutics (SMMT) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Summit Therapeutics has reported Exchange Rate Effect for 8 years, with the latest figure at -$19000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 150.0% year-over-year to -$19000.0; the trailing twelve-month figure through Mar 2026 stood at $45000.0 (down 19.64% YoY), and the FY2025 full-year result was $102000.0, up 666.67% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$19000.0, roughly flat from -$19000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.4 million in Q4 2022, with the low at -$1.8 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$18705.9 across 5 years, with a median of $12000.0 in 2024.
- The largest YoY upside for Exchange Rate Effect was 428.16% in 2022 against a maximum downside of 621.74% in 2022.
- Summit Therapeutics' Exchange Rate Effect stood at $1.4 million in 2022, then plunged by 80.22% to $272000.0 in 2023, then tumbled by 139.71% to -$108000.0 in 2024, then surged by 82.41% to -$19000.0 in 2025, then changed by 0.0% to -$19000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$19000.0 (Q1 2026), -$19000.0 (Q4 2025), and $22000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Summit Therapeutics | 10.09 Bn | 9.99 Bn | - | -19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19,000.00 |
| Mar 31, 2026 | -19,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Dec 31, 2024 | -108,000.00 |
| Dec 31, 2024 | -108,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | -36,000.00 |
| Mar 31, 2024 | -36,000.00 |
| Dec 31, 2023 | 272,000.00 |
| Dec 31, 2023 | 272,000.00 |